Skip to content

DMAC

DiaMedica Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$7.87
+3.96%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-97.9%
Return on equity
-83.4%
Return on assets
-100.9%
Return on invested capital
0.00x
Asset turnover
-$31.6M
Cash from operations
$0.81
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026